Overview
Profile
Experience
Kim & Chang (2006-Present)
Representative MattersView All
- Represented a global pharmaceutical company in patent infringement and invalidation actions before Korean courts and the Intellectual Property Trial and Appeal Board (an appellate body within the Korean Intellectual Property Office), against a local company who was planning to manufacture and sell the infringing product worldwide
- Built and managed a patent portfolio for a multinational pharmaceutical company to secure a patent barrier against biosimilars
- Represented a cosmetic company in patent infringement and invalidation lawsuits against a competitor who improperly practiced the client's technology in violation of the license contract
- Defended a seed company in litigation against a Plant Variety Right (PVR) owner who argued that the client's seeds are biologically identical to the PVR-protected seeds and constitute infringement
- Search for potential business partners for a client in the pharmaceutical industry by patent mapping
- Conducted freedom-to-operate analyses for a food manufacturing process and provided validity/patentability opinions on multiple patents to assist a license contract
- Evaluated trade secret technology of a target company for merger and acquisition
- Represented a pharmaceutical company in a multinational trade secret dispute for misappropriation of a drug-production strain and manufacturing process
Representative ActivitiesView All
Awards
- Notable Stars, Managing IP STARS (Euromoney, 2023)
- IAM Patent 1000: The World's Leading Patent Professionals (IAM, 2023-2024)
- Notable Stars, Managing IP STARS (Euromoney, 2022)
- Rising Star of the Year in IP, Asia Women in Business Law Awards (Euromoney, 2020)
Education
George Washington University, School of Law, LL.M. (2012-2013)
Korea Advanced Institute of Science and Technology (B.S., Biological sciences, 2003)
Qualifications
Admitted to patent bar, Korea, 2005
Languages
Korean and English
Insights
-
Newsletters
In Silico Data as a Basis for Supporting or Denying Patentability in Korea
2024.10.31 -
Recognitions
Kim & Chang Named in IAM Patent 1000: The World's Leading Patent Professionals 2024
2024.06.06 -
Recognitions
Kim & Chang Ranked Again as a Top Law Firm in Korea – Managing IP STARS 2024
2024.05.20 -
Newsletters
Korean District Court Recognizes Infringement of Pfizer's Patent for Prevenar 13® Based on Extraterritorial Activity
2024.01.09 -
Newsletters
Korean Courts Enforce Generic's Obligation to Pay Royalties in Exchange for Data Provided Under a Joint Development Agreement
2023.10.19 -
Recognitions
Kim & Chang Ranked Again as a Top Law Firm in Korea – Managing IP STARS 2023
2023.10.03